Literature DB >> 11906637

Diagnosis and treatment of Wilson's disease.

Michael L Schilsky1.   

Abstract

Wilson's disease (WD) has moved on from being a recognized syndrome that was uniformly fatal to a curative disease for which the genetic basis has been discovered. Most pediatric patients present with hepatic manifestations, but some may have neurologic or psychiatric features. Clinical and biochemical screening, including liver biopsy for hepatic copper analysis, remain the standard for diagnosis, but haplotype analysis for siblings is now available and should be considered for family screening when possible. Lifelong medical therapy remains the mainstay of treatment, but treatment preferences are changing from penicillamine to alternative agents such as trientine and zinc. OLT remains lifesaving for those with fulminant WD and those in whom initial medical therapy fails. The future will probably see the application of rapid and accurate molecular diagnostic testing for this disorder and new therapeutic modalities such as hepatocyte transplantation, gene replacement therapy, and gene modification.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11906637     DOI: 10.1034/j.1399-3046.2002.1r069.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  12 in total

1.  A new mutation of Wilson's disease P-type ATPase gene in a patient with cirrhosis and coombs-positive hemolytic anemia.

Authors:  Lorenzo Leggio; Giovanni Addolorato; Georgios Loudianos; Ludovico Abenavoli; Maria Barbara Lepori; Fabio Maria Vecchio; Gian Ludovico Rapaccini; Stefano De Virgiliis; Giovanni Gasbarrini
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

2.  Liver transplantation for Wilson disease.

Authors:  Andreea M Catana; Valentina Medici
Journal:  World J Hepatol       Date:  2012-01-27

Review 3.  Imaging in liver transplantation.

Authors:  Settimo Caruso; Roberto Miraglia; Luigi Maruzzelli; Salvatore Gruttadauria; Angelo Luca; Bruno Gridelli
Journal:  World J Gastroenterol       Date:  2009-02-14       Impact factor: 5.742

4.  Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests.

Authors:  Jessica D Korman; Irene Volenberg; Jody Balko; Joe Webster; Frank V Schiodt; Robert H Squires; Robert J Fontana; William M Lee; Michael L Schilsky
Journal:  Hepatology       Date:  2008-10       Impact factor: 17.425

Review 5.  Imaging in pediatric liver transplantation.

Authors:  L Monti; G Soglia; P Tomà
Journal:  Radiol Med       Date:  2016-02-24       Impact factor: 3.469

6.  Liver mitochondrial membrane crosslinking and destruction in a rat model of Wilson disease.

Authors:  Hans Zischka; Josef Lichtmannegger; Sabine Schmitt; Nora Jägemann; Sabine Schulz; Daniela Wartini; Luise Jennen; Christian Rust; Nathanael Larochette; Lorenzo Galluzzi; Veronique Chajes; Nathan Bandow; Valérie S Gilles; Alan A DiSpirito; Irene Esposito; Martin Goettlicher; Karl H Summer; Guido Kroemer
Journal:  J Clin Invest       Date:  2011-04       Impact factor: 14.808

7.  Urinary copper/zinc ratio: a promising parameter for replacement of 24-hour urinary copper excretion for diagnosis of Wilson's disease in children.

Authors:  Jian-She Wang; Yi Lu; Xiao-Hong Wang; Qi-Rong Zhu
Journal:  World J Pediatr       Date:  2010-02-01       Impact factor: 2.764

8.  Do cytokines have any role in Wilson's disease?

Authors:  M K Goyal; S Sinha; S A Patil; V Jayalekshmy; A B Taly
Journal:  Clin Exp Immunol       Date:  2008-10       Impact factor: 4.330

9.  Wilson's disease: an analysis of 28 Brazilian children.

Authors:  Rodolpho Truffa Kleine; Renata Mendes; Renata Pugliese; Irene Miura; Vera Danesi; Gilda Porta
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

10.  Copper chelation with tetrathiomolybdate suppresses adjuvant-induced arthritis and inflammation-associated cachexia in rats.

Authors:  Atsushi Omoto; Yutaka Kawahito; Igor Prudovsky; Yasunori Tubouchi; Mizuho Kimura; Hidetaka Ishino; Makoto Wada; Makie Yoshida; Masataka Kohno; Rikio Yoshimura; Toshikazu Yoshikawa; Hajime Sano
Journal:  Arthritis Res Ther       Date:  2005-08-08       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.